HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.

Abstract
The mammalian SWI/SNF chromatin remodeling complex, an essential epigenetic regulator, contains either a single Brm or BRG1 molecule as its catalytic subunit. We observed frequent loss of Brm expression but not of BRG1 in human gastric cancer cell lines. Treatment with histone deacetylase inhibitor rescued Brm expression, indicating epigenetic regulation of this gene, and an RNA interference-based colony formation assay revealed antioncogenic properties of Brm. Brm immunostaining of 89 primary gastric cancers showed an obvious reduction in 60 cases (67%) and a severe decrease in 37 cases (42%). Loss of Brm is frequent in the major gastric cancer types (well- or moderately-differentiated tubular adenocarcinoma and poorly-differentiated adenocarcinoma) and positively correlates with the undifferentiated state. Among the minor gastric cancer types, Brm expression persists in signet-ring cell carcinoma and mucinous adenocarcinoma, but a marked decrease is observed in papillary adenocarcinoma. Intestinal metaplasia never shows decreased expression, indicating that Brm is a valid marker of gastric oncogenesis. In contrast, BRG1 is retained in most cases; a concomitant loss of BRG1 and Brm is rare in gastric cancer, contrary to other malignancies. We further show that Brm is required for villin expression, a definitive marker of intestinal metaplasia and differentiation. Via regulating such genes important for gut differentiation, Brm should play significant roles in determining the histologic features of gastric malignancy.
AuthorsNobutake Yamamichi, Ken-ichi Inada, Masao Ichinose, Mitsue Yamamichi-Nishina, Taketoshi Mizutani, Hirotaka Watanabe, Kazuya Shiogama, Mitsuhiro Fujishiro, Takuya Okazaki, Naohisa Yahagi, Takeshi Haraguchi, Shuji Fujita, Yutaka Tsutsumi, Masao Omata, Hideo Iba
JournalCancer research (Cancer Res) Vol. 67 Issue 22 Pg. 10727-35 (Nov 15 2007) ISSN: 1538-7445 [Electronic] United States
PMID18006815 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • Microfilament Proteins
  • SMARCA2 protein, human
  • Transcription Factors
  • villin
Topics
  • Adenocarcinoma (metabolism)
  • Cell Differentiation
  • Cell Line, Tumor
  • Colorectal Neoplasms (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Epigenesis, Genetic
  • Gastric Mucosa (metabolism)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Histone Deacetylase Inhibitors
  • Humans
  • Microfilament Proteins (biosynthesis)
  • Models, Biological
  • Stomach Neoplasms (metabolism)
  • Transcription Factors (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: